American billionaire Elon Musk spoke about his company “Neuralink” (Neuralink) approaching implanting the first electronic chip in the brain, in a plan that opens the door to various uses. Musk said, during his attendance at the “Vivatech” technology conference in Paris, that “Neuralink” intends to implant the chip in the brain of a patient with hemiplegia or complete paralysis later this year. Musk did not specify the number of patients who will undergo surgery to implant electronic chips or the duration of the operation. Musk, who holds the position of CEO of “Tesla” (Tesla) for electric cars and for the social media platform “Twitter” (Twitter) and for “Space X” (Space X), said that one of the first applications targeted from implanting chips is restoring vision and enabling movement. For the muscles of people who are unable to do so, he said in previous statements, “Even if the person was never sighted, such as being born blind, we still think that we can restore sight to him.” Neuralink is developing chip links for the brain that it says could give patients with disabilities the ability to move and communicate again, and has conducted its experiments on animals in recent years. The company confirmed last month that it had obtained approval from the US Food and Drug Administration to conduct its first clinical trial on humans, a milestone for the emerging company at a time when it is facing investigations in the United States over how it conducts animal trials. Experts told Reuters earlier that Neuralink, if it can prove that its devices are safe for humans, will take several years or perhaps more than a decade to obtain a license for commercial use.